Please login to the form below

Not currently logged in
Email:
Password:

Pharmaceutical Market Europe (PME)

PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.

PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.

From: Regulatory

First Herceptin biosimilar cleared in Europe

Roche Herceptin trastuzumab cancerOntruzant is approved for all the same indications as Roche’s blockbuster

From: Regulatory

EMA forges closer ties with HTA umbrella group

European Medicines Agency (EMA) - logoAgrees joint work plan with the European Network for Health Technology Assessment

From: Regulatory

Novartis' orphan drug Tasigna wins EU expanded indication

Novartis HQThe CML medication can now treat paediatric patients

From: Regulatory

Concordia accused of overcharging NHS for thyroid drug

CMAThe pharma firm said to have ‘abused’ its position within the UK market

Articles

Pharmaceutical Market Europe - November 2017

In the November issue of PME behaviour change looms large, with Sanofi’s global head of patient solutions Dr Anne Beal talking to us about the company’s new behavioural science advisory board

Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app

Editor - Dominic Tyer

Have your say...

Annalisa Jenkins joins biomarker firm PlaqueTec as CEO

She arrives from US-based Dimension Therapeutics, where she was CEO

Annalisa Jenkins

'Nothing about us without us'

Why patient engagement is essential throughout the entire product life cycle

Meike Wenzel

What value for innovation in an era dominated by affordability?

Pharma can collaborate but must be clear about its motives

Peter Shand

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

At M&F Health we deliver real and lasting impact for our clients.We specialise in health and wellbeing, education and environment,...

Latest intelligence

Shining a light on the true cost of patient care
Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore how the proposed national patient data sharing scheme would change the NHS...
city
The real-world data conundrum
How data is changing the healthcare industries...
Where is health behaviour change heading?
Cures rely on patient adherence to succeed, and health behaviour change in any non-compliant patient is essential, this post explores where health behaviour change is heading....

Infographics